Apogee Therapeutics (NASDAQ:APGE) Beats Q1 Estimates with Strong Cash Runway and Promising Clinical Progress
Apogee Therapeutics Inc APGE
$78.75
▼ -2.95%
($-2.39)
Open
$81.46
Prev Close
$81.14
Day Range
$78.33 – $82.00
52W Range
$34.34 – $95.32
Market Cap
$5.93B
Beta
0.58
EPS (TTM)
$-4.22
📋 Company Profile
| Industry | Biotechnology |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2023-07-14 |
| Shares Out. | 74,040,000 |
| Website | apogeetherapeutics.com/ ↗ |
| Phone | 13026587581 |
Apogee Therapeutics Inc is a publicly traded company under the ticker symbol APGE on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
23 analysts (2026-05-01)